Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
CZR Caesars Entertainment Inc
NFLX Netflix Inc
REGN Regeneron Pharmaceuticals Inc
NSC Norfolk Southern Corp
WM Waste Management Inc
ITOS Iteos Therapeutics Inc
CCLD CareCloud Inc
JEF Jefferies Financial Group Inc
RSASF Resaas Services Inc
Go

Health Care : Biotechnology | Large Cap Value
Company profile

AbbVie Inc. is a research-based biopharmaceutical company, which is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in various therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica and Venclexta; aesthetics products that include Botox Cosmetic, Juvederm Collection and others; neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye care products consists of Lumigan, Alphagan and Restasis; women's health products include Lo Loestrin, Orilissa and others; and other products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. Its products are sold to wholesalers, government agencies, health care facilities and independent retailers. It also discovers and develop antibody medicines that target difficult-to-drug disease-causing proteins, such as G protein-coupled receptors (GPCRs).

Postmarket

Last Trade
Delayed
$145.48
0.34 (0.23%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$145.14
Day's Change
0.12 (0.08%)
Bid
--
Ask
--
B/A Size
--
Day's High
145.46
Day's Low
143.66
Volume
(Average)
Volume:
5,394,547

10-day average volume:
5,131,649
5,394,547
  • Prev Close
    145.02
  • Today's Open
    144.58
  • Day's Range
    143.66-145.46
  • Avg Vol (10-day)
    5.1M
  • Last (time)
    4:03p ET 02/07/23
  • Last (size)
    770.2K
  • 52-Wk Range
    134.09 - 175.91
    LowHigh
  • (04/08/22 - 09/30/22)
    8.24%
  • 22.7%
  • Market Cap
    256.7B
  • Shares Outstanding
    1.8B
  • 7.51
  • 19.32x
  • $5.92/4.08%
  • Ex-dividend Date
    01/12/23
  • Dividend Pay Date
    02/15/23
  • 0.6
  • 68.12
  • (% of float 01/13/23)
    0.68

Latest News

February 06, 2023
4:33 pm ET
MarketWatch
February 03, 2023
4:33 pm ET
MarketWatch
February 02, 2023
4:33 pm ET
MarketWatch
February 01, 2023
4:33 pm ET
MarketWatch
January 31, 2023
4:33 pm ET
MarketWatch
January 30, 2023
4:34 pm ET
MarketWatch
January 27, 2023
4:33 pm ET
MarketWatch
January 26, 2023
4:33 pm ET
MarketWatch
January 25, 2023
4:33 pm ET
MarketWatch
11:42 am ET
PR Newswire
January 24, 2023
4:33 pm ET
MarketWatch
January 23, 2023
4:33 pm ET
MarketWatch
January 21, 2023
4:10 pm ET
MarketWatch
January 20, 2023
4:33 pm ET
MarketWatch
January 19, 2023
4:33 pm ET
MarketWatch
January 18, 2023
4:33 pm ET
MarketWatch
8:00 am ET
PR Newswire
January 17, 2023
4:33 pm ET
MarketWatch
8:00 am ET
PR Newswire
January 16, 2023
9:00 am ET
Globe Newswire
January 14, 2023
8:20 am ET
MarketWatch
January 13, 2023
4:33 pm ET
MarketWatch
January 12, 2023
4:33 pm ET
MarketWatch
January 11, 2023
4:33 pm ET
MarketWatch
January 10, 2023
4:33 pm ET
MarketWatch
8:00 am ET
PR Newswire
January 09, 2023
4:34 pm ET
MarketWatch
4:33 pm ET
MarketWatch
12:48 pm ET
MarketWatch
7:59 am ET
MarketWatch
January 06, 2023
4:33 pm ET
MarketWatch
8:00 am ET
PR Newswire
8:00 am ET
BusinessWire
January 05, 2023
5:11 pm ET
MarketWatch
4:33 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.